Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Longevica Appoints Prasun Mishra As Chief Executive Officer
PRIVATESep 07, 2026•about 10 hours ago
Position
Chief Executive Officer
Company
Longevica Therapeutics
Prasun Mishra
BiotechnologyHealth Care
Description
Longevica Therapeutics has announced the appointment of Dr. Prasun Mishra as CEO. With his extensive experience in biopharmaceuticals, Mishra will guide the company in translating their innovative mouse dataset into FDA-approved drugs.
Company Information
Company
Longevica Therapeutics
About
Longevica Therapeutics is focused on the development of drugs aimed at extending lifespan through extensive research in mammalian longevity. The company has spent four years and $13 million on testing to find viable therapeutic candidates. They aim to translate their findings from preclinical data to real-world applications, overcoming challenges faced in the longevity sector.
Don't miss Longevica Therapeutics's next move
Get an email the moment Longevica Therapeutics changes its leadership, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Predictive Intelligence
Strategic
ML-powered predictions for Longevica Therapeutics's next move